Verdad Advisers’s CVS Health CVS Stock Holding History

Verdad Advisers’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,700	Closed	-$409K	–	227
2026 Q1	$409K	Sell	5,700 -10,005	-64%	-$771K	0.46%	79
2025 Q4	$1.25M	Buy	+15,705	New	+$1.24M	1.43%	22

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Verdad Advisers's CVS Position: Q2 2026 in Review

Verdad Advisers sold out of CVS Health (CVS) in Q2 2026, closing a stake of 5,700 shares — an estimated $409K sold.

Verdad Advisers first reported a position in CVS in Q4 2025 and held it in 2 quarters. The position peaked at $1.25M in Q4 2025. 2,066 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Verdad Advisers reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
Verdad Advisers sold 5,700 CVS Health shares in Q2 2026, an estimated $409K.
Verdad Advisers first reported a position in CVS Health in Q4 2025 and held it in 2 quarters.
Verdad Advisers's CVS Health position peaked at $1.25M in Q4 2025.
2,066 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.